NO171852C - Analogifremgangsmaate for fremstilling av terapeutisk aktive cefemforbindelser med to substituerte 5-leddede ringer - Google Patents
Analogifremgangsmaate for fremstilling av terapeutisk aktive cefemforbindelser med to substituerte 5-leddede ringerInfo
- Publication number
- NO171852C NO171852C NO873640A NO873640A NO171852C NO 171852 C NO171852 C NO 171852C NO 873640 A NO873640 A NO 873640A NO 873640 A NO873640 A NO 873640A NO 171852 C NO171852 C NO 171852C
- Authority
- NO
- Norway
- Prior art keywords
- substituted
- preparation
- therapeutically active
- ring rings
- analogy procedure
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/18—7-Aminocephalosporanic or substituted 7-aminocephalosporanic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
- C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
- C07D501/46—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cephalosporin Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB868622766A GB8622766D0 (en) | 1986-09-22 | 1986-09-22 | Cephem compounds |
| GB868628061A GB8628061D0 (en) | 1986-11-24 | 1986-11-24 | Cephem compounds |
| GB878705072A GB8705072D0 (en) | 1987-03-04 | 1987-03-04 | Cephem compounds |
| GB878711653A GB8711653D0 (en) | 1987-05-18 | 1987-05-18 | Cephem compounds |
| GB878716437A GB8716437D0 (en) | 1987-07-13 | 1987-07-13 | Cephem compounds |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| NO873640D0 NO873640D0 (no) | 1987-08-28 |
| NO873640L NO873640L (no) | 1988-03-23 |
| NO171852B NO171852B (no) | 1993-02-01 |
| NO171852C true NO171852C (no) | 1993-05-12 |
Family
ID=27516672
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO873640A NO171852C (no) | 1986-09-22 | 1987-08-28 | Analogifremgangsmaate for fremstilling av terapeutisk aktive cefemforbindelser med to substituerte 5-leddede ringer |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | US4927818A (fi) |
| EP (1) | EP0261615B1 (fi) |
| JP (2) | JPH064647B2 (fi) |
| KR (1) | KR950013566B1 (fi) |
| CN (1) | CN87106452A (fi) |
| AU (2) | AU607157B2 (fi) |
| CA (1) | CA1293719C (fi) |
| DE (1) | DE3788261T2 (fi) |
| DK (1) | DK460087A (fi) |
| ES (1) | ES2061462T3 (fi) |
| FI (1) | FI87925C (fi) |
| HU (1) | HU202540B (fi) |
| IE (1) | IE872329L (fi) |
| IL (1) | IL83760A (fi) |
| NO (1) | NO171852C (fi) |
| NZ (1) | NZ221843A (fi) |
| OA (1) | OA08665A (fi) |
| PH (1) | PH23767A (fi) |
| PT (1) | PT85762B (fi) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ198350A (en) * | 1980-09-25 | 1985-02-28 | Toyama Chemical Co Ltd | Cephalosporins and intermediates;pharmaceutical compositions |
| CA1293719C (en) * | 1986-09-22 | 1991-12-31 | Takao Takaya | Cephem compounds and processes for preparation thereof |
| US5162520A (en) * | 1986-09-22 | 1992-11-10 | Fujisawa Pharmaceutical Co., Ltd. | Intermediates for cephem compounds |
| IL86941A (en) * | 1987-07-10 | 1993-07-08 | Gist Brocades Nv | Process for the preparation of cephem compounds and some new cephalosporin derivatives prepared by this process |
| US5210080A (en) * | 1987-09-07 | 1993-05-11 | Fujisawa Pharmaceutical Co., Ltd. | Cephem compounds |
| US5663163A (en) * | 1987-09-07 | 1997-09-02 | Fujisawa Pharmaceutical Co., Ltd. | Cephem compounds and processes for preparation thereof |
| GB8905301D0 (en) * | 1989-03-08 | 1989-04-19 | Fujisawa Pharmaceutical Co | New cephem compound and a process for preparation thereof |
| KR910015587A (ko) * | 1990-02-27 | 1991-09-30 | 후지사와 토모키치로 | 세펨 화합물 |
| US5604222A (en) * | 1993-12-27 | 1997-02-18 | Lupin Laboratories, Ltd. | Method for the preparation of 2-chloro sulfinyl azetidinones |
| US5578721A (en) * | 1994-07-11 | 1996-11-26 | Lupin Laboratories Limited | Process for preparation of 3-exomethylene cepham sulfoxide esters |
| PL366507A1 (en) * | 2001-05-01 | 2005-02-07 | Fujisawa Pharmaceutical Co, Ltd. | Cephem compounds |
| ES2290498T7 (es) * | 2002-10-30 | 2015-07-10 | Astellas Pharma Inc. | Compuestos de cefem |
| AU2003902380A0 (en) * | 2003-05-16 | 2003-06-05 | Fujisawa Pharmaceutical Co., Ltd. | Cephem compounds |
| KR20060069475A (ko) * | 2003-09-18 | 2006-06-21 | 아스텔라스세이야쿠 가부시키가이샤 | 세펨 화합물 |
| JP4758371B2 (ja) * | 2007-02-23 | 2011-08-24 | 株式会社荻野精機製作所 | 動力伝達切換機構 |
| PT3616695T (pt) | 2011-09-09 | 2024-11-18 | Merck Sharp & Dohme | Ceftolozano/tazobactam para tratar infeções intrapulmonares |
| US8809314B1 (en) | 2012-09-07 | 2014-08-19 | Cubist Pharmacueticals, Inc. | Cephalosporin compound |
| US8476425B1 (en) | 2012-09-27 | 2013-07-02 | Cubist Pharmaceuticals, Inc. | Tazobactam arginine compositions |
| CN102875572B (zh) * | 2012-10-26 | 2014-07-30 | 四川科伦药物研究有限公司 | 一种硫酸头孢噻利中间体的精制方法 |
| CN110279698B (zh) | 2013-03-15 | 2022-10-28 | 默沙东有限责任公司 | 头孢特咯瓒抗生素组合物 |
| US20140274990A1 (en) | 2013-03-15 | 2014-09-18 | Cubist Pharmaceuticals, Inc. | Ceftolozane pharmaceutical compositions |
| US9872906B2 (en) | 2013-03-15 | 2018-01-23 | Merck Sharp & Dohme Corp. | Ceftolozane antibiotic compositions |
| CN105377812B (zh) | 2013-06-21 | 2018-09-18 | 组合化学工业株式会社 | 2-氨基-2-肟基-n-烷氧基亚氨代乙酰基氰化物的制备方法及其制备中间体 |
| ES2800603T3 (es) | 2013-09-09 | 2021-01-04 | Merck Sharp & Dohme | Tratamiento de infecciones con ceftolozano/tazobactam en sujetos con insuficiencia renal |
| US8906898B1 (en) | 2013-09-27 | 2014-12-09 | Calixa Therapeutics, Inc. | Solid forms of ceftolozane |
| WO2015196077A1 (en) * | 2014-06-20 | 2015-12-23 | Merck Sharp & Dohme Corp. | Reactions of thiadiazolyl-oximinoacetic acid derivative compounds |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4268509A (en) * | 1978-07-10 | 1981-05-19 | Fujisawa Pharmaceutical Co., Ltd. | New cephem compounds and processes for preparation thereof |
| DK480679A (da) * | 1978-11-15 | 1980-05-16 | Glaxo Group Ltd | Fremgangsmaade til fremstilling af cephalosporinforbindelser |
| US4390534A (en) * | 1978-12-29 | 1983-06-28 | Fujisawa Pharmaceutical Co., Ltd. | Cephem and cepham compounds |
| US4332800A (en) * | 1979-10-12 | 1982-06-01 | Fujisawa Pharmaceutical Co., Ltd. | Cephem compounds |
| ZA816321B (en) * | 1980-09-12 | 1982-09-29 | Ciba Geigy | Ammoniomethyl compounds,processes for their manufacture,pharmaceutical preparations that contain these compounds,and the use of these compounds |
| GR78245B (fi) * | 1980-09-12 | 1984-09-26 | Ciba Geigy Ag | |
| US4431642A (en) * | 1980-12-01 | 1984-02-14 | Fujisawa Pharmaceutical Co., Ltd. | Cephem compounds |
| JPS584789A (ja) * | 1981-04-03 | 1983-01-11 | Fujisawa Pharmaceut Co Ltd | 新規セフエム化合物およびその製造法 |
| ES511101A0 (es) * | 1981-04-03 | 1983-05-01 | Fujisawa Pharmaceutical Co | "procedimiento para preparar un nuevo compuesto de cefem". |
| GR75487B (fi) * | 1981-06-22 | 1984-07-23 | Fujisawa Pharmaceutical Co | |
| US4521413A (en) * | 1981-09-14 | 1985-06-04 | Fujisawa Pharmaceutical Co., Ltd. | Cephem compounds |
| US4563449A (en) * | 1982-07-19 | 1986-01-07 | Fujisawa Pharmaceutical Co., Ltd. | Cephem compounds |
| DE3419012A1 (de) * | 1984-05-22 | 1985-11-28 | Bayer Ag, 5090 Leverkusen | Ss-lactamantibiotika, verfahren zu deren herstellung sowie ihre verwendung als arzneimittel oder wachstumsfoerderer in der tieraufzucht oder als antioxidantien |
| PH22107A (en) * | 1984-06-07 | 1988-06-01 | Takeda Chemical Industries Ltd | 3-pyrazolo(1,5-a)pyrdinium cephem compounds |
| JPS61286389A (ja) * | 1985-06-11 | 1986-12-16 | Eisai Co Ltd | セフエム系化合物 |
| CN86107947A (zh) * | 1985-11-22 | 1987-05-27 | 藤沢药品工业株式会社 | 新的头孢烯化合物及其制备方法 |
| CA1293719C (en) * | 1986-09-22 | 1991-12-31 | Takao Takaya | Cephem compounds and processes for preparation thereof |
| IE63094B1 (en) * | 1987-09-14 | 1995-03-22 | Fujisawa Pharmaceutical Co | Cephem compound and a process for preparation thereof |
-
1987
- 1987-08-26 CA CA000545415A patent/CA1293719C/en not_active Expired - Fee Related
- 1987-08-28 NO NO873640A patent/NO171852C/no unknown
- 1987-08-28 US US07/090,345 patent/US4927818A/en not_active Expired - Fee Related
- 1987-08-31 PH PH35750A patent/PH23767A/en unknown
- 1987-08-31 IE IE872329A patent/IE872329L/xx unknown
- 1987-09-02 IL IL83760A patent/IL83760A/xx not_active IP Right Cessation
- 1987-09-03 DK DK460087A patent/DK460087A/da not_active Application Discontinuation
- 1987-09-09 JP JP62225787A patent/JPH064647B2/ja not_active Expired - Lifetime
- 1987-09-17 NZ NZ221843A patent/NZ221843A/xx unknown
- 1987-09-18 AU AU78671/87A patent/AU607157B2/en not_active Ceased
- 1987-09-19 DE DE87113726T patent/DE3788261T2/de not_active Expired - Fee Related
- 1987-09-19 EP EP87113726A patent/EP0261615B1/en not_active Expired - Lifetime
- 1987-09-19 ES ES87113726T patent/ES2061462T3/es not_active Expired - Lifetime
- 1987-09-21 CN CN198787106452A patent/CN87106452A/zh active Pending
- 1987-09-21 PT PT85762A patent/PT85762B/pt not_active IP Right Cessation
- 1987-09-21 HU HU874258A patent/HU202540B/hu unknown
- 1987-09-21 FI FI874102A patent/FI87925C/fi not_active IP Right Cessation
- 1987-09-21 KR KR1019870010461A patent/KR950013566B1/ko not_active Expired - Fee Related
- 1987-09-22 OA OA59199A patent/OA08665A/xx unknown
-
1989
- 1989-09-06 US US07/403,406 patent/US5108997A/en not_active Expired - Fee Related
-
1990
- 1990-11-28 AU AU67077/90A patent/AU642929B2/en not_active Ceased
-
1993
- 1993-06-25 JP JP5154852A patent/JPH0680064B2/ja not_active Expired - Lifetime
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO171852C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive cefemforbindelser med to substituerte 5-leddede ringer | |
| NO801415L (no) | Fremgangsmaate for fremstilling av antibakterielt aktive bisestere av metandiol med penicillinderivater | |
| NO150206C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive hoeyredreiende spiro-hydantoinforbindelser | |
| NO844879L (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive indolderivater | |
| NO168174C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive triazolforbindelser | |
| NO872946D0 (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzensulfonamidoindanylforbindelser. | |
| NO172581C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive tricykliske ketoner | |
| NO162113C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive fenetanolaminforbindelser. | |
| NO171913C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive tricykliske forbindelser | |
| NO810762L (no) | Fremgangsmaate for fremstilling av farmakologisk aktive heterocykliske forbindelser | |
| NO780883L (no) | Analogifremgangsmaate for fremstilling av farmakologisk aktive 4-acylamino-fenyl-etanolaminer | |
| NO864879D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive tiasolforbindelser. | |
| NO914490D0 (no) | Analogifremgangsmaate for fremstilling av terapeutisk virksomme tricykliske forbindelser | |
| NO169438C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive tetrazolforbindelser | |
| NO168362C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive peptidforbindelser | |
| NO151201C (no) | Fremgangsmaate for fremstilling av terapeutisk virksomme antigenderivater | |
| NO820493L (no) | Analogifremgangsmaate for fremstilling av farmakologisk aktive azepinderivater | |
| NO871867D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske kondenserte tricykliske forbindelser. | |
| NO172849C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazol- og oksazol-derivater | |
| NO145762C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive antracyklinglykosidiske forbindelser | |
| NO152255C (no) | Analogifremgangsmaate for fremstilling av terapeutisk virksomme imidazolylvinylethere | |
| NO165842C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive cefem-forbindelser. | |
| NO834729L (no) | Fremgangsmaate for fremstilling av farmakologisk aktive tio-cefalosporiner | |
| NO170582C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive aryl-piperazinyl-alkylenfenyl-heterocykliske forbindelser | |
| NO151239C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-fenyliminoimidazolidiner |